SN7
SHORT NOTE
5M
Describe the placebo effect with its mechanisms, uses and ethical considerations.
Definitions
| Term | Meaning |
|---|---|
| Placebo | An inert substance or procedure given as if it were an active treatment |
| Placebo effect | The beneficial effect produced by expectation and by the therapeutic setting, rather than by any pharmacological action |
| NOCEBO effect | Adverse effects produced by negative expectation |
| Active placebo | A substance producing a recognisable but therapeutically irrelevant effect, used to preserve blinding where the real drug has obvious side effects |
The Placebo Response
- It is a real and measurable phenomenon, not merely imagination or reporting bias
- Placebo analgesia is mediated partly by endogenous opioids and is reversed BY naloxone — the single most compelling evidence that a genuine physiological mechanism is involved
- Objective changes have been demonstrated — altered brain imaging, dopamine release in Parkinson disease, and measurable immune and endocrine responses
- Effect size is greatest for subjective outcomes — pain, nausea, anxiety, insomnia, depression — and least for objective ones such as tumour size
- Around 30 to 40% of patients may respond, though the figure varies widely with the condition and setting
Factors Influencing the Response
| Factor | Influence |
|---|---|
| The doctor’s manner and confidence | Probably the strongest single factor — enthusiasm and a clear explanation increase the response |
| The patient’s expectation | Belief in the treatment enhances it; scepticism reduces it |
| Physical characteristics of the preparation | Larger tablets, capsules rather than tablets, injections rather than tablets, and coloured or expensive-looking preparations all produce greater responses |
| The condition treated | Greatest for pain, anxiety, insomnia, irritable bowel and depression |
| Setting and ritual | The consultation itself, and the act of being treated |
CLINICAL PEARL
The placebo effect is part of every treatment, not an alternative to it. When an active drug is given, its measured benefit is the pharmacological effect plus the placebo component. That is precisely why a control group is indispensable — without one, the two cannot be separated, and natural recovery is credited to the drug.
Uses and Ethical Problems
| Use | Assessment |
|---|---|
| As a control in randomised trials | The principal and entirely legitimate use; without it, efficacy cannot be established |
| To enhance an active treatment | Legitimate — a confident explanation and a good therapeutic relationship recruit the effect honestly, without deception |
| As deceptive treatment in practice | Ethically problematic — it requires deceiving the patient, breaches informed consent, and destroys trust if discovered |
| To "prove" that pain is not real | Invalid and harmful — a response to placebo says nothing about whether pain is organic; patients with unmistakably organic pain respond to placebo |
- Withholding a placebo control is unethical when an effective treatment exists — the comparator must then be the standard treatment, not an inert one
Applied Aspects
- The commonest misuse of placebo is to test whether pain is "genuine". This reasoning is simply wrong, and leads to patients with real disease being disbelieved and under-treated
- Use the effect honestly — explain the treatment clearly, express appropriate confidence, and give the consultation adequate time; these measurably improve outcome and require no deception
- Be aware of the NOCEBO effect when listing side effects — how the information is framed influences how many are experienced, though patients must still be told what matters
- Placebo response is why uncontrolled observations mislead, and why testimonial evidence for unproven remedies is so persuasive and so unreliable
- Alternative and traditional remedies derive much of their apparent benefit from this effect; the appropriate response is to test them properly rather than to dismiss or to accept them uncritically
All questions in General Pharmacology: Pharmacodynamics
- Q1Describe the mechanisms of drug action. Classify receptors and describe their signal transduction mechanisms. ★
- Q2Describe the dose-response relationship. Explain potency, efficacy, agonists, antagonists and the therapeutic index. ★
- Q3Define adverse drug reaction. Classify adverse drug reactions and describe their mechanisms. Add a note on pharmacovigilance. ★
- Q4Describe the factors modifying drug action and dosage. Add a note on tolerance and the placebo effect. ★
- Q5Describe the stages of drug development and the phases of clinical trial. Explain the essential features of a good clinical trial. ★
- SN1Define therapeutic index. Explain its significance with examples. ★
- SN2Define partial agonist and inverse agonist. Give examples and their clinical significance. ★
- SN3Define tolerance and tachyphylaxis. Describe their mechanisms with examples. ★
- SN4Classify drug antagonism with examples. Add a note on synergism. ★
- SN5Define teratogenicity. Describe the critical periods and the important teratogenic drugs. ★
- SN6Define essential medicines. Describe the criteria for selection and the principles of rational prescribing. ★
- SN7Describe the placebo effect with its mechanisms, uses and ethical considerations.